Rosa Willock
Rosa Willock is Senior Consultant at Decisive Consulting Ltd.
JournalA key role for the European Medicines Agency in the European Union’s Health Technology Assessment Regulation
The need for early collaboration between regulators and European Union’s (EU) Health Technology Assessment (HTA) bodies when developing ‘fit-for-purpose’ evidence generation plans has long been acknowledged, and the ‘Health Technology Assessment (EU) 2021/2282’ (EU-HTAR) Regulation will be the first permanent collaboration between the European Medicines Agency (EMA) and HTA ...